We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Submission status for ELI LILLY AND CO's drug RETEVMO (SUPPL-9) with active ingredient SELPERCATINIB has changed to 'Approval' on 11/16/2026."
"FDA approved a 11/16/2026 efficacy labeling supplement (SUPPL-18) for Lilly's RETEVMO (selpercatinib) NDA 213246, a label update, not a Supplement ..."
"you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition ..."
"Possible thyroid tumors, including cancer. · Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary ..."
"Medullary thyroid cancer RET and NTRK 1, 2, and 3 tests. Cholangiocarcinoma (bile duct cancer) FGFR2 and IDH1 tests. Gastrointestinal stromal ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.